These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 7325295

  • 21. [Psychiatric indications of drugs used in clinical practice].
    Bacaltchuk J.
    Rev Paul Med; 1987; 105(6):336-40. PubMed ID: 3332928
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Antistress and antineurotic action of psychotropic preparations in experiments on monkeys].
    Startsev VG, Mamamtavrishvili SK, Chirkova SK, Chirkov AM, Dzholiia TM.
    Vestn Akad Med Nauk SSSR; 1986; (3):30-3. PubMed ID: 3705719
    [No Abstract] [Full Text] [Related]

  • 24. [Psychophysiological analysis of the effects of psychopharmacological drugs on memory and attention in patients with limited neuropsychological disorders].
    Aleksandrovskiy YuA, Benkovich BI, Marshak OV.
    Sante Publique (Bucur); 1989; 32(4):385-93. PubMed ID: 2799622
    [No Abstract] [Full Text] [Related]

  • 25. Chronic treatments in neuropsychiatry.
    Adv Biochem Psychopharmacol; 1985; 40():1-219. PubMed ID: 4025031
    [No Abstract] [Full Text] [Related]

  • 26. [Use and misuse of psychotropic drugs].
    Bojanovsky J.
    Fortschr Med; 1977 Nov 17; 95(43):2613-6. PubMed ID: 914218
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Action of 1694 in the treatment of structured and unstructured neurotic states with psychasthenic, anxio-phobic and depression manifestations].
    Bornstein S, Tournoux C, Kamoun A, Labet R.
    Sem Hop Ther; 1976 Jan 17; 52(1):15-7. PubMed ID: 1257796
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Treatment of cognitive impairment secondary to degenerative dementia. Effectiveness of oxiracetam therapy.
    Rozzini R, Zanetti O, Bianchetti A.
    Acta Neurol (Napoli); 1993 Feb 17; 15(1):44-52. PubMed ID: 8456595
    [Abstract] [Full Text] [Related]

  • 36. [Psychoneurotic disorders in patients with chronic pancreatitis and their correction].
    Piskunov GG, Khazanov AI, Lukomskiĭ MI.
    Voen Med Zh; 1988 Dec 17; (12):35-6. PubMed ID: 3242258
    [No Abstract] [Full Text] [Related]

  • 37. Placebo-psychotherapy combinations: inappropriate representations of psychotherapy in drug-psychotherapy comparative trials.
    Hollon SD, DeRubeis RJ.
    Psychol Bull; 1981 Nov 17; 90(3):467-77. PubMed ID: 7029596
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [DIAZEPAM (VALIUM) IN NERVOUS ANXIETY AND TENSION. DOUBLE BLIND EXPERIMENT WITH PLACEBO CONTROL AND THE USE OF SEQUENTIAL ANALYSIS].
    LINGJAERDE O.
    Tidsskr Nor Laegeforen; 1964 Oct 15; 84():1426-8. PubMed ID: 14226936
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.